Table 4.
Mean Periodontal Pocket Depth, Mean Clinical Attachment Loss, and Mean Alveolar Bone Height Loss (in mm) between 0 and 12 months and 12 and 18 months
| Periodontal |
Attachment Loss |
Alveolar bone height |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | Est.* | Std. Error |
P-Value | Est. | Std. Error |
P-Value | Est | Std. Error | P-Value |
| Intercept | 1.9 | 0.21 | <.001 | 1.4 | 0.23 | <.001 | 2.42 | 0.17 | <.001 |
| Time | |||||||||
| Baseline | Ref | Ref | Ref | ||||||
| 6 Months | −0.08 | 0.03 | 0.02 | −0.03 | 0.04 | 0.52 | NA | NA | NA |
| 12 Months | 0.06 | 0.03 | 0.04 | 0.11 | 0.04 | 0.020 | 0.13 | 0.04 | <0.001 |
| 18 Months | 0.13 | 0.04 | <0.001 | 0.17 | 0.04 | <0.001 | 0.27 | 0.04 | <0.001 |
| AI use | |||||||||
| Not on AI | −0.23 | 0.08 | 0.008 | −0.44 | 0.20 | 0.038 | 0.27 | 0.20 | 0.19 |
| On AI | Ref | Ref | Ref | ||||||
| History of periodontal cleanings | |||||||||
| No | 0.21 | 0.07 | 0.05 | 0.35 | 0.12 | 0.04 | 0.86 | 0.29 | 0.052 |
| Yes | Ref | Ref | Ref | ||||||
| Bisphosphonate use at baseline (Y/N) | |||||||||
| No Bisphosphonate use | 0.06 | 0.06 | 0.36 | 0.23 | 0.14 | 0.12 | 0.04 | 0.17 | 0.81 |
| Bisphosphonate use | Ref | Ref | Ref | ||||||
| Dental insurance | |||||||||
| No | 0.10 | 0.07 | 0.15 | −0.01 | 0.16 | 0.95 | 0.12 | 0.05 | 0.16 |
| Yes | Ref | Ref | Ref | ||||||
| Adjuvant chemotherapy | |||||||||
| No | 0.11 | 0.08 | 0.20 | 0.29 | 0.18 | 0.13 | −0.20 | 0.21 | 0.39 |
| Yes | Ref | Ref | Ref | ||||||
| Vitamin D supplement use at baseline | |||||||||
| No Vitamin D | −0.03 | 0.06 | 0.69 | 0.07 | 0.15 | 0.65 | −0.15 | 0.17 | 0.37 |
| Vitamin D | Ref | Ref | Ref | ||||||
| Calcium supplement use at baseline | |||||||||
| No Calcium use | 0.02 | 0.07 | 0.69 | −0.05 | 0.20 | 0.81 | 0.81 | 0.27 | 0.005 |
| Calcium use | Ref | Ref | Ref | ||||||
| Not on Calcium and Not on AI Baseline Interaction | −0.17 | 0.12 | 0.17 | −0.17 | 0.27 | 0.53 | −0.70 | 0.34 | 0.04 |
Est Estimates of Fixed Effects
Ref Reference group